Research Peptide Labeling Requirements: What FDA Regulations Mandate

If you supply or handle research peptides in the United States, your labels must comply with FDA regulations. This article covers the core requirements under 21 CFR 801 (Labeling) and 21 CFR 820.120 (Quality System Regulation), and explains what "research use only" statements must include to be compliant and legally defensible.

21 CFR Part 801: General labeling rules

21 CFR 801 sets out fundamental labeling requirements that apply to FDA-regulated products, including research chemicals and peptides:

• Legibility and clarity: Labels must be clear, conspicuous, and legible under normal storage and use conditions. Font size, contrast, and durability matter.
• Required information: Product identity, quantity, manufacturer or distributor name and address, and any required warnings or restrictions.
• Accuracy: Label statements must be truthful and not misleading. This includes claims about intended use, purity, and identity.

21 CFR 820.120: Quality System labeling controls

For manufacturers following good manufacturing practices (GMP), 21 CFR 820.120 requires specific labeling controls:

• Design specifications (DHF): Labeling design (artwork, text, dimensions) must be documented in the design history file with version control.
• Label inspection: Labels must be inspected to ensure they match specifications before application to products.
• Storage and handling: Labels must be stored and handled to prevent damage, fading, or degradation that would compromise readability.
• Obsolescence control: Outdated label stock must be removed from circulation to prevent use of incorrect or expired labeling.

What "research use only" disclaimers must say

A statement such as "For Laboratory Research Only — Not for Human or Animal Consumption" is a standard and defensible disclaimer for research peptides. However, the FDA has clarified that a RUO disclaimer alone does not exempt a product from drug classification if evidence establishes that the product is intended for human use.

Effective labeling should include:

• Explicit restriction: "For in-vitro laboratory research only" or "For research purposes only"
• Age restriction: "Must be 21 years of age or older to purchase"
• No human/animal use: "Not for human or animal consumption, injection, or medical use"
• No medical claims: Avoid any language suggesting therapeutic benefit, efficacy, or safety in humans

Certificate of Analysis (COA) as labeling documentation

A comprehensive COA is an extension of product labeling. It should include:

• Lot number and date of manufacture
• Identity confirmation: HPLC retention time, mass spectrometry m/z, or NMR spectroscopy data
• Purity assay: HPLC % purity (or AAA for absolute quantification)
• Impurities: Known degradation products or synthesis byproducts quantified
• Microbial testing: Sterile filtration confirmation or microbial limit testing if applicable
• Authenticity statement: Signed attestation that the product is for research use only

Common labeling mistakes to avoid

• Vague or missing intended use: Labels should explicitly state "for research" or "for in-vitro use only," not just "for laboratory use" (which is ambiguous).
• Implied therapeutic claims: Avoid phrases like "supports healthy aging" or "promotes recovery" — even in small print. These trigger drug classification.
• Missing version control on labels: If you update a label, all old stock must be removed. Mixing versions causes confusion and regulatory risk.
• Inadequate storage instructions: Labels should state "Store at 2–8°C" or "Store at −20°C" as appropriate, with expiration date.

Sources & further reading

• FDA — Quality System Regulation Labeling Requirements
• FDA — 21 CFR Part 801: Labeling
• FDA — 21 CFR Part 820: Quality System Regulation

Universe Peptide publishes research-focused education for the scientific community. Products are for laboratory research only. See more in our News & research updates.